Skip to main content
Top
Published in: Journal of Nephrology 5/2019

01-10-2019 | Anemia | Original Article

Role of anemia and proteinuria in the development of subsequent renal function deterioration in a general population with preserved glomerular filtration rate: a community-based cohort study

Authors: Hiroyuki Kiriyama, Hidehiro Kaneko, Hidetaka Itoh, Yuriko Yoshida, Koki Nakanishi, Yoshiko Mizuno, Masao Daimon, Hiroyuki Morita, Yutaka Yatomi, Issei Komuro

Published in: Journal of Nephrology | Issue 5/2019

Login to get access

Abstract

Background

Risk factors for renal function deterioration in the general population are not fully understood. We aimed to clarify the determinants of estimated glomerular filtration rate (eGFR) decline using a community-based cohort.

Methods and results

Among 3217 subjects who underwent repeated health check-ups, we excluded 478 subjects with eGFR ≤ 60 mL/min/1.73 m2 and examined 2739 subjects. EGFR decline rate was calculated from the difference in eGFR between the first and last visits. EGFR decline, which was defined as a drop in GFR accompanied by a 25% or greater drop in eGFR from baseline and/or a sustained decline of more than 5 mL/min/1.73 m2/year, was observed in 209 subjects (7.6%). Anemia according to the WHO definition (16.7% vs. 11.7%, p = 0.03), and proteinuria (3.3% vs. 0.8%, p < 0.001) at baseline were more commonly observed in subjects with eGFR decline. Multivariable logistic regression analysis showed that anemia and proteinuria were independently associated with eGFR decline.

Conclusion

Anemia and proteinuria were closely related to eGFR decline, which suggests that we should consider these parameters as risk factors of the development of renal function deterioration even in the general population.
Appendix
Available only for authorised users
Literature
1.
go back to reference Epstein M (1996) Aging and the kidney. J Am Soc Nephrol 7(8):1106–1122PubMed Epstein M (1996) Aging and the kidney. J Am Soc Nephrol 7(8):1106–1122PubMed
2.
go back to reference Coresh J, Turin TC, Matsushita K, Sang Y, Ballew SH, Appel LJ et al (2014) Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA 311(24):2518–2531CrossRefPubMedCentralPubMed Coresh J, Turin TC, Matsushita K, Sang Y, Ballew SH, Appel LJ et al (2014) Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA 311(24):2518–2531CrossRefPubMedCentralPubMed
3.
go back to reference Cheng TY, Wen SF, Astor BC, Tao XG, Samet JM, Wen CP (2008) Mortality risks for all causes and cardiovascular diseases and reduced GFR in a middle-aged working population in Taiwan. Am J Kidney Dis 52(6):1051–1060CrossRefPubMed Cheng TY, Wen SF, Astor BC, Tao XG, Samet JM, Wen CP (2008) Mortality risks for all causes and cardiovascular diseases and reduced GFR in a middle-aged working population in Taiwan. Am J Kidney Dis 52(6):1051–1060CrossRefPubMed
4.
go back to reference Van Pottelbergh G, Den Elzen WPJ, Degryse J, Gussekloo J (2013) Prediction of mortality and functional decline by changes in eGFR in the very elderly: the Leiden 85-plus study. BMC Geriatr 13:61CrossRefPubMedCentralPubMed Van Pottelbergh G, Den Elzen WPJ, Degryse J, Gussekloo J (2013) Prediction of mortality and functional decline by changes in eGFR in the very elderly: the Leiden 85-plus study. BMC Geriatr 13:61CrossRefPubMedCentralPubMed
5.
go back to reference Rein P, Saely CH, Muendlein A, Vonbank A, Drexel H (2010) Serial decline of kidney function as a novel biomarker for the progression of atherothrombotic disease. Atherosclerosis 211(1):348–352CrossRefPubMed Rein P, Saely CH, Muendlein A, Vonbank A, Drexel H (2010) Serial decline of kidney function as a novel biomarker for the progression of atherothrombotic disease. Atherosclerosis 211(1):348–352CrossRefPubMed
6.
go back to reference Al-Aly Z, Zeringue A, Fu J, Rauchman MI, McDonald JR, El-Achkar TM et al (2010) Rate of kidney function decline associates with mortality. J Am Soc Nephrol 21(11):1961–1969CrossRefPubMedCentralPubMed Al-Aly Z, Zeringue A, Fu J, Rauchman MI, McDonald JR, El-Achkar TM et al (2010) Rate of kidney function decline associates with mortality. J Am Soc Nephrol 21(11):1961–1969CrossRefPubMedCentralPubMed
8.
go back to reference Lee SC, Daimon M, Di Tullio MR, Homma S, Hasegawa T, Chiou SH et al (2018) Beneficial effect of body weight control on left ventricular diastolic function in the general population: an analysis of longitudinal data from a health check-up clinic. Eur Heart J Cardiovasc Imaging 19(2):136–142CrossRefPubMed Lee SC, Daimon M, Di Tullio MR, Homma S, Hasegawa T, Chiou SH et al (2018) Beneficial effect of body weight control on left ventricular diastolic function in the general population: an analysis of longitudinal data from a health check-up clinic. Eur Heart J Cardiovasc Imaging 19(2):136–142CrossRefPubMed
9.
go back to reference Blanc B, Finch CA, Hallberg L (1968) Nutritional anemias report of a WHO scientific group. WHO Tech Rep Ser 405:1–40 Blanc B, Finch CA, Hallberg L (1968) Nutritional anemias report of a WHO scientific group. WHO Tech Rep Ser 405:1–40
10.
go back to reference Kaneko H, Neuss M, Okamoto M, Weissenborn J, Butter C (2018) Impact of preprocedural anemia on outcomes of patients with mitral regurgitation who underwent mitraclip implantation. Am J Cardiol 122(5):859–865CrossRefPubMed Kaneko H, Neuss M, Okamoto M, Weissenborn J, Butter C (2018) Impact of preprocedural anemia on outcomes of patients with mitral regurgitation who underwent mitraclip implantation. Am J Cardiol 122(5):859–865CrossRefPubMed
11.
go back to reference Lamb EJ, MacKenzie F, Stevens PE (2009) How should proteinuria be detected and measured? Ann Clin Biochem 46:205–217CrossRefPubMed Lamb EJ, MacKenzie F, Stevens PE (2009) How should proteinuria be detected and measured? Ann Clin Biochem 46:205–217CrossRefPubMed
12.
go back to reference Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K et al (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53(6):982–992CrossRefPubMed Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K et al (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53(6):982–992CrossRefPubMed
13.
go back to reference Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA et al (2014) KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis 63(5):713–735CrossRefPubMed Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA et al (2014) KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis 63(5):713–735CrossRefPubMed
14.
go back to reference Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL et al (2003) Kidney disease as a risk factor for development of cardiovascular disease—a statement from the American Heart Association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation 108(17):2154–2169CrossRefPubMed Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL et al (2003) Kidney disease as a risk factor for development of cardiovascular disease—a statement from the American Heart Association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation 108(17):2154–2169CrossRefPubMed
15.
go back to reference Go AS, Chertow GM, Fan DJ, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. New Engl J Med 351(13):1296–1305CrossRefPubMed Go AS, Chertow GM, Fan DJ, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. New Engl J Med 351(13):1296–1305CrossRefPubMed
16.
go back to reference Kovesdy CP, Trivedi BK, Anderson JE (2006) Association of kidney function with mortality in patients with chronic kidney disease not yet on dialysis: a historical prospective cohort study. Adv Chronic Kidney Dis 13(2):183–188CrossRefPubMed Kovesdy CP, Trivedi BK, Anderson JE (2006) Association of kidney function with mortality in patients with chronic kidney disease not yet on dialysis: a historical prospective cohort study. Adv Chronic Kidney Dis 13(2):183–188CrossRefPubMed
17.
go back to reference Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJ, Mann JF et al (2013) Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet (Lond, Engl) 382(9889):339–352CrossRef Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJ, Mann JF et al (2013) Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet (Lond, Engl) 382(9889):339–352CrossRef
18.
go back to reference Turin TC, James M, Ravani P, Tonelli M, Manns BJ, Quinn R et al (2013) Proteinuria and rate of change in kidney function in a community-based population. J Am Soc Nephrol 24(10):1661–1667CrossRefPubMedCentralPubMed Turin TC, James M, Ravani P, Tonelli M, Manns BJ, Quinn R et al (2013) Proteinuria and rate of change in kidney function in a community-based population. J Am Soc Nephrol 24(10):1661–1667CrossRefPubMedCentralPubMed
19.
go back to reference Rosansky SJ, Hoover DR, King L, Gibson J (1990) The association of blood pressure levels and change in renal function in hypertensive and nonhypertensive subjects. Arch Intern Med 150(10):2073–2076CrossRefPubMed Rosansky SJ, Hoover DR, King L, Gibson J (1990) The association of blood pressure levels and change in renal function in hypertensive and nonhypertensive subjects. Arch Intern Med 150(10):2073–2076CrossRefPubMed
20.
go back to reference Hemmelgarn BR, Zhang J, Manns BJ, Tonelli M, Larsen E, Ghali WA et al (2006) Progression of kidney dysfunction in the community-dwelling elderly. Kidney Int 69(12):2155–2161CrossRefPubMed Hemmelgarn BR, Zhang J, Manns BJ, Tonelli M, Larsen E, Ghali WA et al (2006) Progression of kidney dysfunction in the community-dwelling elderly. Kidney Int 69(12):2155–2161CrossRefPubMed
21.
go back to reference Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW et al (1994) The effects of dietary-protein restriction and blood-pressure control on the progression of chronic renal-disease. New Engl J Med 330(13):877–884CrossRefPubMed Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW et al (1994) The effects of dietary-protein restriction and blood-pressure control on the progression of chronic renal-disease. New Engl J Med 330(13):877–884CrossRefPubMed
22.
go back to reference Ikeda N, Saito E, Kondo N, Inoue M, Ikeda S, Satoh T et al (2011) Japan: universal health care at 50 years 1 What has made the population of Japan healthy? Lancet (Lond, Engl) 378(9796):1094–1105CrossRef Ikeda N, Saito E, Kondo N, Inoue M, Ikeda S, Satoh T et al (2011) Japan: universal health care at 50 years 1 What has made the population of Japan healthy? Lancet (Lond, Engl) 378(9796):1094–1105CrossRef
23.
go back to reference Hsu CY, Iribarren C, McCulloch CE, Darbinian J, Go AS (2009) Risk factors for end-stage renal disease 25-year follow-up. Arch Intern Med 169(4):342–350CrossRefPubMedCentralPubMed Hsu CY, Iribarren C, McCulloch CE, Darbinian J, Go AS (2009) Risk factors for end-stage renal disease 25-year follow-up. Arch Intern Med 169(4):342–350CrossRefPubMedCentralPubMed
24.
go back to reference Iseki K, Ikemiya Y, Iseki C, Takishita S (2003) Hematocrit and the risk of developing end-stage renal disease. Nephrol Dial Transpl 18(5):899–905CrossRef Iseki K, Ikemiya Y, Iseki C, Takishita S (2003) Hematocrit and the risk of developing end-stage renal disease. Nephrol Dial Transpl 18(5):899–905CrossRef
25.
go back to reference Chang WX, Arai S, Tamura Y, Kumagai T, Ota T, Shibata S et al (2016) Time-dependent risk factors associated with the decline of estimated GFR in CKD patients. Clin Exp Nephrol 20(1):58–70CrossRefPubMed Chang WX, Arai S, Tamura Y, Kumagai T, Ota T, Shibata S et al (2016) Time-dependent risk factors associated with the decline of estimated GFR in CKD patients. Clin Exp Nephrol 20(1):58–70CrossRefPubMed
26.
go back to reference Semama D, Heumann C, Guignard JP (1995) Protection from hypoxemic renal dysfunction by verapamil and manganese in the rabbit. Life Sci 56(4):231–239CrossRefPubMed Semama D, Heumann C, Guignard JP (1995) Protection from hypoxemic renal dysfunction by verapamil and manganese in the rabbit. Life Sci 56(4):231–239CrossRefPubMed
27.
go back to reference Pozzoli S, Simonini M, Manunta P (2018) Predicting acute kidney injury: current status and future challenges. J Nephrol 31(2):209–223CrossRefPubMed Pozzoli S, Simonini M, Manunta P (2018) Predicting acute kidney injury: current status and future challenges. J Nephrol 31(2):209–223CrossRefPubMed
28.
go back to reference Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K et al (2011) The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies conference report. Kidney Int 80(1):17–28CrossRefPubMed Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K et al (2011) The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies conference report. Kidney Int 80(1):17–28CrossRefPubMed
29.
go back to reference Gansevoort RT, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS et al (2011) Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int 80(1):93–104CrossRefPubMedCentralPubMed Gansevoort RT, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS et al (2011) Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int 80(1):93–104CrossRefPubMedCentralPubMed
30.
go back to reference Imai E, Horio M, Yamagata K, Iseki K, Hara S, Ura N et al (2008) Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study. Hypertens Res 31(3):433–441CrossRefPubMed Imai E, Horio M, Yamagata K, Iseki K, Hara S, Ura N et al (2008) Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study. Hypertens Res 31(3):433–441CrossRefPubMed
Metadata
Title
Role of anemia and proteinuria in the development of subsequent renal function deterioration in a general population with preserved glomerular filtration rate: a community-based cohort study
Authors
Hiroyuki Kiriyama
Hidehiro Kaneko
Hidetaka Itoh
Yuriko Yoshida
Koki Nakanishi
Yoshiko Mizuno
Masao Daimon
Hiroyuki Morita
Yutaka Yatomi
Issei Komuro
Publication date
01-10-2019
Publisher
Springer International Publishing
Published in
Journal of Nephrology / Issue 5/2019
Print ISSN: 1121-8428
Electronic ISSN: 1724-6059
DOI
https://doi.org/10.1007/s40620-019-00605-2

Other articles of this Issue 5/2019

Journal of Nephrology 5/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.